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Abstract
Background: The clinical traits of Kufs disease (KD) type B (CLN13), an adult-onset neuronal ceroid lipofuscinosis
(NCL), are well established according to the neurological features of the cases reported with mutations in CTSF.
The neuroradiological characteristics of this uncommon disease have not yet been outlined.
Case presentation: We hereby report the brain MRI features in two Caucasian women who carried homozygous
mutations in CTSF, providing a short review of the neuroradiological findings of other common NCLs.
Together with a brain volume reduction, the two cases showed white matter hyperintensities and thinning of the
corpus callosum at onset of the cognitive decline.
Conclusion: White matter hyperintensities associated with volume reduction of the corpus callosum may be
present at the beginning of the behavioural changes in CLN13 and represent further clues for searching mutations
in CTSF.
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Background
Mutations in CTSF/CLN13, encoding cathepsin F, have
recently been reported in Kufs disease (KD) type B (MIM
606725) [1, 2], an autosomal recessive, adult-onset, neur-
onal ceroid lipofuscinosis (NCL). The clinical features of
this rare form of NCL are well established on the basis of
findings in ten patients in four families and include de-
mentia with motor disturbances, commonly associated
with facial dyskinesias, in the absence of visual failure. The
detection of fingerprint profiles or granular osmiophilic
deposits by electron microscopy was mandatory for defini-
tive diagnosis, although the significance of the biopsy in
the diagnostic process of KD has been recently questioned
[3], and then significantly reduced by the cloning of CTSF.
From a clinical standpoint, absence of visual impair-
ment in young adults showing cognitive decline with a
possible autosomal recessive inheritance should suggest
CLN13. Although diffuse cerebral atrophy was detected
in four cases belonging to three unrelated Caucasian
families [1], the neuroradological features of such disease
remain largely undescribed. The report of the neuroradio-
logical changes and the time-frame in which these features
are highlighted in additional patients with mutations in
CTSF may represent a useful support for the clinician
to disclose potential CLN13 both in sporadic and fa-
milial cases.
We report the results of brain MRI in two KD patients
already described in full elsewhere [2].
Case presentation
A 43-year-old woman (case 1) presented at the age of
23 years clusters of tonic-clonic seizures, fully controlled
by a combination of sodium valproate (1250 mg/day)
and carbamazepine (1200 mg/day). Her previous medical
history was unremarkable except for several mild head
traumas. No MRI scan were obtained at that time. From
the age of 30, the patient showed rapid cognitive decline,
postural tremor, sporadic myoclonic jerks in the lower
limbs, and transient facial dyskinesias. Her vision was
preserved. Brain MRI showed cerebral atrophy, mainly
in the parieto-occipital regions, cerebellar atrophy and
T2-weighted hyperintensities in the periventricular areas
(Fig. 1).
A 45-year-old woman (case 2), a cousin of case 1, had
experienced tonic-clonic seizures since the age of 21,
controlled by sodium valproate (1000 mg/day), phenobar-
bital (100 mg/day) and zonesamide (200 mg/day). In her
30s, the patient developed cognitive impairment, ideomotor
apraxia, cerebellar dysarthria and inappropriate laughter.
Her sight was spared. Brain MRI, carried out when the
* Correspondence: rodifa@gmail.com
1Department of Medical-Surgical Sciences and Biotechnologies, Sapienza
University of Rome, Corso della Repubblica 79, Latina, Italy
Full list of author information is available at the end of the article
© 2015 Di Fabio et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Di Fabio et al. BMC Neurology  (2015) 15:102 
DOI 10.1186/s12883-015-0357-6
neurological signs were noted, showed cortico-subcortical
atrophy, periventricular white matter hyperintensities on
T2-weighted scans, cerebellar atrophy, and thinning of the
corpus callosum (Fig. 1).
Both patients belonged to the largest family with KD
type B reported to date in which a homozygous c.213+1G>C
mutation in CTSF was detected [2].
Conclusion
We here reported the neuroradiological characteristics
of two additional patients with KD type B in which, to-
gether with brain volume reduction, early periventricular
and deep white matter hyperintensities and atrophy of
corpus callosum were detected.
Careful neuroimaging in patients with suspected NCL
may confirm the diagnosis, opening the way for genetic
counselling and providing a basis for neurological screening
in other family members. In this regard, a detailed report
on the neuroradiological features of patients with this rare
form of NCL could be crucial to disclose new potential dis-
ease carriers when clinical features emerge.
The cerebral and cerebellar volume loss seen on neuro-
imaging in our patients are not features pathognomonic of
CLN13, having also been described in cases of adult-onset
Fig. 1 Brain MRI imaging in two patients with Kufs disease type B. Case 1. Axial T2-TSE (a and b), coronal T2-FLAIR (c), and sagittal T1-TSE (d) sections
at onset of cognitive impairment showing cortico-subcortical atrophy, predominant in the parieto-occipital regions and the cerebellum, white matter
hyperintensities and thinning of the corpus callosum (arrow). Case 2. Images at onset of cognitive impairment: axial T2-TSE (a1), coronal T2-FLAIR (b1)
and sagittal T1-TSE (c1) sections displayed brain atrophy, mainly involving the cerebellum, periventricular hyperintensities and thinning of the corpus
callosum (arrow). Follow up imaging: axial T2-TSE (a2) and coronal T2-FLAIR (b2) and sagittal T1-TSE (c2) scans taken in the same patient 9 years later
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NCL due to mutations in DNAJC5 [4], CLN6 [5], CLN5
[6] and in patients with mutations in GRN [7].
Ceroid, lipofuscin-like, is an autofluorescent pigment,
resistant to lipid solvents, that accumulates in the lyso-
somes not as part of normal senescence [8]. Neuronal
loss, astrocytic proliferation and macrophage infiltration
may result in the macroscopic changes disclosed by neu-
roimaging in CLN13, as observed in other NCLs [9].
Symmetrical hyperintensities in the dentate nucleus
and hypointense thalami [10, 11], a typical finding in
palmitoyl protein thioesterase-1-related NCL, were not
found in our KD patients. The periventricular high-
signals on T2-weighted images as well as the narrowing
of callosal commissure were also detected in classic
infantile-onset NCLs [12], but are not commonly seen in
adult-onset NCLs both in genetically-confirmed [4–7]
and clinically diagnosed cases [13–15]. According to our
findings, these MRI changes, occurring at the onset of
the neurological syndrome, may represent clues for a
diagnosis of CLN13, although a detailed study of neuro-
imaging in additional KD type B cases is warranted to
support this assumption.
In summary, in familial cases with early, adult-onset,
autosomal-recessive cognitive decline without visual fail-
ure, brain atrophy as well as periventricular white matter
hyperintensities and thinning of the corpus callosum
should alert clinicians to a possible diagnosis of CLN13.
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